OH Pharma
Products › Skin and aesthetics › GHK-Cu 50 mg
GHK-Cu 50 mg OH PharmaGHK-Cu 50 mg OH Pharma – back of vial

Skin and aesthetics · File 09

GHK-Cu 50 mg

Certificate of analysis available

✓Sterility and endotoxins tested by Nelson Labs (Salt Lake City)

Purity (HPLC)99.7 %
LotGN2605
LaboratoryBTLabs
Calculate a dose →

Description

Complex of a tripeptide (glycyl‑histidyl‑lysine) and copper, naturally present in human plasma.

Studied benefits

  • Stimulation of collagen synthesis in fibroblast cultures.
  • Effects on tissue remodelling and wound repair in experimental models.
  • Cosmetic potential to improve the appearance of skin and wrinkles, but clinical evidence is still limited and mixed.

Results reported in published research; they guarantee no effect and are not an indication for use.

🔬 What the research says
  • Human studies mainly cover topical use in skin care. Injection has not been studied in humans.
⚠️ Warnings and reported side effects
  • Possible injection-site reactions.
  • Injectable safety profile unknown.

Consult a healthcare professional before any use. If an adverse effect occurs, stop use and see a doctor.

Certificate details

Laboratory
BTLabs (West Palm Beach, FL, United States)
Report number
IF-824-QSA-TR006-BTL26632-03
Substance analyzed
GHK-Cu
Lot
GN2605
Analysis date
June 1, 2026
Report date
June 5, 2026
Labelled sample content
50 mg
Sample ID
005000040271681

Results

TestMethodSpecificationResult
Identity and composition (FTIR)USP <197A>Confirms the presence of the peptideConfirmedPass
Purity (HPLC)USP <621>≥ 98 %99.7 %Pass
Measured content (HPLC)USP <621>90 – 110 % de 50 mg53.4 mg (106.8 %)Pass
Total massUSP <41>As measured138.5 mg

According to the laboratory, this analysis covers identity, purity, content and composition. It does not cover particulates, microbial contamination or endotoxins. Sterility and endotoxins are tested separately by Nelson Labs (Salt Lake City, Utah).

How to read this certificate →

Original certificate

Certificate of analysis GHK-Cu 50 mg, page 1Certificate of analysis GHK-Cu 50 mg, page 2 Download the certificate (PDF)

Sources

  1. Published studies on GHK‑Cu (PubMed)
  2. Health Canada — advisory on unauthorized injectable peptides (April 2026)

For educational purposes only. This information summarizes published studies and is neither a recommendation for use nor medical advice.

← Back to products